October 2026
1. MERSALI S, Chapelle R, Ribeiro M, Weiss N, et al
   Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy.
   Neurology. 2026;107:e218561.
   

   >> Share

   
   August 2026
2. HORTA L, de Souza BLV, Martinez-Lage M, Forst D, et al
   Characterization of Clinical Course, Diagnosis, Treatment, and Outcomes of Intravascular Lymphoma With Neurologic Involvement.
   Neurology. 2026;107:e210199.
   

   >> Share

   
   April 2026
3. MULLER KJ, Karschnia P, Kaulen LD, Reis J, et al
   Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features.
   Neurology. 2026;106:e214744.
   

   >> Share

   
   April 2025
4. HERNANDEZ-TOST H, Weiss N, Choquet S, Birzu C, et al
   Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.
   Neurology. 2025;104:e213501.
   

   >> Share

   
   January 2025
5. LUWEN H, Linlin L, Lei X, Ming Y, et al
   Reader Response: Teaching NeuroImage: Fundoscopic and Optical Coherence Tomography Changes in Primary CNS Lymphoma.
   Neurology. 2025;104:e209712.
   

   >> Share

   
   
6. LEWIS A, Galetta SL
   Editors' Note: Teaching NeuroImage: Fundoscopic and Optical Coherence Tomography Changes in Primary CNS Lymphoma.
   Neurology. 2025;104:e210314.
   

   >> Share

   
   
7. MOHEB N, Moheb N, Tobin WO, Olsen TW, et al
   Author Response: Teaching NeuroImage: Fundoscopic and Optical Coherence Tomography Changes in Primary CNS Lymphoma.
   Neurology. 2025;104:e209733.
   

   >> Share

   
   November 2024
8. FANOURAKI S, Theodorou A, Velonakis G, Stavrinou L, et al
   Clinical Reasoning: Progressive Peripheral Neuropathy in a 66-Year-Old Woman With Sezary Syndrome.
   Neurology. 2024;103:e209983.
   

   >> Share

   
   September 2024
9. ITOH CY, Griffin KJ, Yi D, Hooshmand SJ, et al
   Teaching Video NeuroImage: Isolated Presentation of Cavernous Sinus Syndrome From CNS Lymphoma.
   Neurology. 2024;103:e209767.
   

   >> Share

   
   
10. ABOUBAKR O, Houillier C, Alentorn A, Choquet S, et al
    Epilepsy in Patients With Primary CNS Lymphoma: Prevalence, Risk Factors, and Prognostic Significance.
    Neurology. 2024;103:e209748.
    

    >> Share

    
    August 2024
11. AZZIMONTI M, Esposito F, Poliani PL, Gagliardi F, et al
    Teaching NeuroImage: Spontaneously Resolving Ring-Enhancing Lesions Due to Immunodeficiency-Associated CNS Lymphoma: A Case of "Vanishing Lymphoma".
    Neurology. 2024;103:e209644.
    

    >> Share

    
    June 2024
12. HERZI D, Le Garff-Tavernier M, Sourdeau E, Choquet S, et al
    Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network Study.
    Neurology. 2024;102:e209527.
    

    >> Share

    
    
13. MOHEB N, Tobin WO, Olsen TW, Chen JJ, et al
    Teaching NeuroImage: Fundoscopic and Optical Coherence Tomography Changes in Primary CNS Lymphoma.
    Neurology. 2024;102:e209512.
    

    >> Share

    
    March 2024
14. LI CMF, MacDougall K, Fraser JA
    Teaching NeuroImage: Transcalvarial Lymphoma: A Rare Cause of Secondary Intracranial Hypertension.
    Neurology. 2024;102:e209227.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share